PMID: 11336245May 5, 2001Paper

Health system costs of metastatic breast cancer

Breast Cancer Research and Treatment
E S WaiI A Olivotto

Abstract

To assess the costs of treating patients with incurable breast cancer, all health system costs during the interval from diagnosis of first recurrence or metastasis until death for 75 female subjects randomly selected from those known to have died of breast cancer in British Columbia, Canada between July 1, 1995 and December 31, 1996, were identified. Costs were determined from several databases within the British Columbia (BC) Ministry of Health, as well as from BC Cancer Agency patient charts. The mean total cost to the health system was CDN $36,474.33 (95% confidence interval $29,752-$43,196) per subject. The mean costs were highest for the youngest age group and lowest for the middle age group, but these only differed by $2,300. Inpatient costs accounted for the greatest proportion of the total, over 50% in all age groups. This data may be valuable in assessing the cost-effectiveness of interventions that are known to affect mortality due to breast cancer.

References

Jan 1, 1991·Medical Care·M S BakerR C Smucker
Mar 15, 1995·Journal of the National Cancer Institute·S H TaplinP Nefcy
Jan 1, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A OlivottoC Sawka
May 1, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·K H AntmanM M Horowitz
Feb 20, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M CrumpJ Pater

❮ Previous
Next ❯

Citations

Jul 6, 2006·Breast Cancer Research and Treatment·Khalid El OuagariJane Brandman
Mar 6, 2004·Breast Cancer Research and Treatment·S RaoD Gilden
Nov 13, 2010·Journal of Medical Economics·Maureen J LageSue Gao
Oct 25, 2012·The Breast : Official Journal of the European Society of Mastology·Kimberly A BoswellMatti S Aapro
Apr 24, 2007·Cancer·Kathy L Schulman, Joseph Kohles
Jan 10, 2013·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Hla-Hla TheinCraig C Earle
Nov 18, 2004·Oncology Nursing Forum·Denise M OleskeKaren L Nachman
Mar 1, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ivo A OlivottoJoseph Ragaz
Jan 4, 2020·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Kristine KreisAnja Schramm

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Breast Cancer: Chemo-Resistance

Some cancers are difficult to treat and aggressive including the "triple-negative" breast cancer. This type of cancer is chemoresistant even before chemotherapy begins. Here are the latest discoveries chemo-resistance in breast cancer.

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Cancer Incidence & Mortality

Cancer has emerged as a global concern due to its increase in incidence and mortality. Efforts are underway to evaluate and develop action plans to reduce the global burden of cancer. Currently, lung cancer, breast cancer and prostate cancer are the leading causes of cancer mortality. Here is the latest research on cancer incidence and mortality.

Related Papers

Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
N BerkowitzG Silberman
European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
B P WillW K Evans
© 2021 Meta ULC. All rights reserved